MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2021

    Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction

    E. Contaldi, L. Magistrelli, I. Campini, C. Comi (Novara, Italy)

    Objective: To evaluate whether the 123I-FP-CIT striatal uptake differs in Parkinson’s disease (PD) drug-naïve patients with and without sexual dysfunction. Background: Sexual dysfunction is one…
  • MDS Virtual Congress 2021

    Effects of psychiatric tests on disease severity and nonmotor symptoms in early onset Parkinson’s Disease

    A. Tuncer, G. Yuksel, B. Hasırcı (İstanbul, Turkey)

    Objective: Psychiatric tests evaluating symptoms such as depression, anxiety, rumination, obsession, impulsivity, apathy and impulsive compulsive behaviors were applied in patients with early onset PD.…
  • MDS Virtual Congress 2021

    The feasibility of using an internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia

    M. Wadon, M. Winter, K. Peall (Cardiff, United Kingdom)

    Objective: To determine the feasibility of utilising a guided, internet-based, self-help cognitive behavioural therapy (CBT) programme for the management of psychiatric symptoms in patients with…
  • MDS Virtual Congress 2021

    Non-Motor Symptoms Progression After 2 years Follow-up in Parkinson´s Disease. Results from the COPPADIS Cohort and Comparison with a Control Group

    C. Cores Bartolomé, D. García, T. Fonticoba, C. Miró, E. Castro, JM. Gonzalez, S. Maestre, M. Aguilar, P. Pastor, L. Planellas Giné, M. Cosgaya, J. Garcia Caldentey, N. Caballol Pons, I. Legarda Ramirez, J. Hernandez Vara, I. Cabo, L. Lopez Manzanares, I. Gonzalez Aramburu, MA. Avila, MJ. Catalan Alonso, V. Nogueira, V. Puente, JM. Garcia Moreno, C. Borrue Fernandez, B. Solano Vila, M. Alvarez Sauco, L. Vela Desojo, S. Escalante, E. Cubo, F. Carrillo Padilla, JC. Martinez Castrillo, P. Sanchez Alonso, MG. Alonso Losada, N. Lopez Ariztegui, I. Gaston Zubimendi, J. Kulisevsky, M. Blazquez Estrada, M. Seijo Martinez, J. Ruiz Martinez, C. Valero Merino, M. Kurtis, O. de Fábregues-Boixer, J. Gonzalez Ardura, CM. Ordas Bandera, L. Lopez Diaz, P. Mir Rivera, P. Martinez Martin (A Coruña, Spain)

    Objective: The aim of the present study was to analyze the progression of non-motor symptoms (NMS) in PD patients from a Spanish cohort and to compare…
  • MDS Virtual Congress 2021

    A corneal nerve density possible progression biomarker in Parkinson’s disease (PD) patients: pilot study

    S. Yaisawang, J. Sringean, N. Kasetsuwan, R. Bhiyasiri (Bangkok, Thailand)

    Objective: To evaluate corneal sub-basal nerve plexus density in PD compared to age-matched healthy subjects using confocal microscopy Background: Cornea is the most densely innervated…
  • MDS Virtual Congress 2021

    DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare DNMSQuest scores with validated measures of mood disorder in cervical dystonia patients attending a hospital botulinum toxin clinic. We wished to determine…
  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • MDS Virtual Congress 2021

    Subclinical inflammation and Parkinson’s disease

    G. Pagano (Basel, Switzerland)

    Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…
  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • MDS Virtual Congress 2021

    Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease

    H. Jackson, J. Anzures-Cabrera, T. Simuni, R. Postuma, G. Pagano (Welwyn Garden City, United Kingdom)

    Objective: To define a subset of Parkinson’s disease (PD) symptoms that are present in both individuals with early PD and prodromal PD, compared with age-matched…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley